Organigram (NASDAQ:OGI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Organigram (NASDAQ:OGI) announced its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01), Zacks reports. Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Organigram Stock Performance

Shares of NASDAQ OGI opened at $1.47 on Thursday. The business has a fifty day moving average of $1.62 and a two-hundred day moving average of $1.68. Organigram has a 52-week low of $1.21 and a 52-week high of $2.91. The stock has a market cap of $185.45 million, a PE ratio of -3.50 and a beta of 1.02.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.